Most Likely Cause of Death: Perforated Duodenal Ulcer
The most likely cause of death in this patient is a perforated duodenal ulcer (Option A), resulting from prolonged high-dose glucocorticoid therapy without appropriate tapering or gastroprotection.
Clinical Reasoning
This patient received prednisolone 60 mg daily for 12 weeks total (double the prescribed 6-week duration) without tapering. This represents prolonged high-dose glucocorticoid exposure, which carries substantial gastrointestinal risks.
Why Perforated Peptic Ulcer is Most Likely:
Glucocorticoid-induced peptic ulcer disease is a well-established complication:
- High-dose prednisone (>30 mg/day) significantly increases peptic ulcer risk 1
- The FDA label explicitly lists peptic ulcer as a consequence of prolonged prednisolone use 2
- Events occur at rates of 1-4 per 100 patient-years with chronic medium-dose therapy 1
The clinical scenario fits perfectly:
- Found dead in bathtub suggests sudden catastrophic event
- Perforated peptic ulcer causes acute peritonitis, hypovolemic shock, and rapid death
- Patients on high-dose steroids often have blunted pain perception, delaying recognition of perforation until catastrophic
- The bathtub setting suggests she may have been experiencing abdominal discomfort and sought relief in warm water before sudden decompensation
Why Other Options Are Less Likely:
Option B (Hypertensive Cerebral Hemorrhage):
- While hypertension occurs with glucocorticoids (3-28 per 100 patient-years) 1, cerebral hemorrhage is not a predominant cause of death in SLE patients on steroids
- The bimodal mortality pattern in SLE shows early deaths from active disease/infection, late deaths from atherosclerotic cardiovascular disease 3
- Hemorrhagic stroke is not emphasized in glucocorticoid toxicity profiles
Option C (Acute Cerebral Vasculitis):
- This would represent active SLE, but she was on high-dose steroids for 12 weeks
- Active lupus causing death typically occurs early in disease course with inadequate treatment 3
- High-dose glucocorticoids should suppress active vasculitis
Option D (Intestinal Ischemia with Perforation):
- While theoretically possible, this is much rarer than peptic ulcer disease
- Not specifically highlighted in glucocorticoid adverse effect profiles
- Mesenteric vasculitis from SLE would be unlikely given the high steroid dose
Critical Glucocorticoid Toxicity Context
This case illustrates multiple guideline violations:
Excessive duration without taper: Guidelines recommend tapering high-dose glucocorticoids (>30 mg prednisone) relatively quickly 4
Lack of gastroprotection: Patients on medium/high-dose glucocorticoids require monitoring for comorbidities including peptic ulcer disease 1
Dose-related damage: Higher average daily prednisone doses predict organ damage (adjusted HR 1.03 per mg increase) 5
Modern SLE management emphasizes lower doses: Current guidelines recommend limiting prednisone to ≤5 mg daily for long-term use and avoiding prolonged high doses 6, 7, 8
Common Pitfalls to Avoid
- Never continue high-dose glucocorticoids beyond prescribed duration without reassessment
- Always provide gastroprotection (PPI) with medium/high-dose glucocorticoids
- Educate patients about the critical importance of not self-extending steroid courses
- Remember that steroids mask symptoms—patients may have advanced pathology with minimal complaints